Screening In-Depth Focus 2016
Posted: 11 December 2016 | Elisabeth Weber, Kamyar Hadian, Kenji Schorpp, Lee Babiss | No comments yet
In this Screening In-Depth Focus, scientists from the Assay Development and Screening Platform of Helmholtz Zentrum München provide an overview of different high-throughput screening (HTS)-applicable assay types that can be applied to drug discovery campaigns. Plus an interview with Lee Babiss, CEO of drug discovery firm X-Rx, on the benefits and challenges of using DNA-encoded library technology over other screening techniques…
This Screening In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Assays, High-Throughput Screening (HTS), Screening
ForteBio, Helmholtz Zentrum München, IntelliCyt Corporation, Thermo Fisher Scientific, X-Rx
Elisabeth Weber, Kamyar Hadian, Kenji Schorpp, Lee Babiss